TESTBANK
Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 6th Edition
l l l l l l l
Author: Teri Moser Woo and Wendy L. Wright
l l l l l l l
, TABLE OF CONTENT l l
Chapter l 1. l The Role of the Advanced Practice Nurse as Prescriber ................................................................4
l l l l l l l l
Chapter l 2. l Review of Basic Principles of Pharmacology ..................................................................................5
l l l l l
Chapter l 3. l Rational Drug Selection .................................................................................................................. 11
l l
Chapter l 4. l Legal and Professional Issues in Prescribing ................................................................................ 14
l l l l l
Chapter l 5. l Adverse Drug Reactions ................................................................................................................. 16
l l
Chapter l 6. l An Introduction to Pharmacogenomics .......................................................................................... 19
l l l
Chapter l 7. l Nutrition and Nutraceuticals ........................................................................................................... 22
l l
Chapter l 8. l Herbal Therapies .............................................................................................................................. 28
l
Chapter 9. Cannabis ........................................................................................................................................... 31
l l
Chapter 10. Pharmacoeconomics ....................................................................................................................... 35
l l
Chapter 11. Drugs Affecting the Autonomic Nervous System ...................................................................... 38
l l l l l l l
Chapter 12. Drugs Affecting the Central Nervous System ............................................................................. 45
l l l l l l l
Chapter 13. Drugs Affecting the Cardiovascular and Renal Systems ............................................................ 53
l l l l l l l l
Chapter 14. Drugs Affecting the Respiratory System ..................................................................................... 61
l l l l l l
Chapter 15. Drugs Affecting the Hematological System ................................................................................ 65
l l l l l l
Chapter 16. Drugs Affecting the Immune System: Vaccines and Immunoglobulins .................................... 69
l l l l l l l l l
Chapter 17. Drugs Affecting the Immune System: Immunomodulators ......................................................... 75
l l l l l l l
Chapter 18. Drugs Affecting the Gastrointestinal System ............................................................................... 77
l l l l l l
Chapter 19. Drugs Affecting the Endocrine System: Pancreatic Hormones and Antidiabetic Drugs .............. 80
l l l l l l l l l l l
Chapter 20. Drugs Affecting the Endocrine System: Pituitary, Thyroid, and Adrenal Drugs...................... 83
l l l l l l l l l l l
Chapter 21. Drugs Affecting the Reproductive System .................................................................................. 86
l l l l l l
Chapter 22. Drugs Affecting the Bones and Joints ......................................................................................... 92
l l l l l l l
Chapter 23. Drugs Affecting the Integumentary System ................................................................................. 96
l l l l l l
Chapter 24. Drugs Used to Treat Bacterial Infections ...................................................................................101
l l l l l l l
Chapter 25. Drugs Used to Treat Viral, Fungal, and Protozoal Infections ..................................................105
l l l l l l l l l l
Chapter 26. Drugs Used to Treat Inflammatory Processes ............................................................................108
l l l l l l l
Chapter 27. Drugs Used to Treat Eye and Ear Disorders .............................................................................111
l l l l l l l l l
Chapter 28. Anemia ..........................................................................................................................................113
l l
Chapter 29. Anxiety and Depression ...............................................................................................................116
l l l l
Chapter l 30. l Attention Deficit-Hyperactivity Disorder ....................................................................................120
l l
Chapter l 31. l Asthma and Allergy .....................................................................................................................122
l l
Chapter l 32. l Chronic Obstructive Pulmonary Disease .....................................................................................125
l l l
Chapter l 33. l Contraception ................................................................................................................................127
Chapter l 34. l COVID-19: Acute and Chronic ...................................................................................................130
l l l
Chapter 35. l l Dermatological Conditions ...........................................................................................................134
l
Chapter 36. l l Diabetes Management ..................................................................................................................138
l
Chapter 37.l l Gastroesophageal Reflux and Peptic Ulcer Disease...................................................................146
l l l l l
Chapter 38. l l Headaches......................................................................................................................................149
Chapter 39. Heart Failure .................................................................................................................................153
l l l
Chapter 40. HIV Disease and Acquired Immunodeficiency Syndrome .........................................................158
l l l l l l l
Chapter 41. Menopausal Hormone Therapy....................................................................................................161
l l l l
,Chapter 42. Hyperlipidemia ..............................................................................................................................164
l l
Chapter 43. Hypertension .................................................................................................................................169
l l
Chapter 44. Hyperthyroidism and Hypothyroidism ........................................................................................174
l l l l
Chapter 45. Obesity ..........................................................................................................................................177
l l
Chapter 46. Pain Management: Acute and Chronic Pain...............................................................................181
l l l l l l l
Chapter 47. Pneumonia .....................................................................................................................................185
l l
Chapter 48. Sexually Transmitted Diseases and Vaginitis .............................................................................187
l l l l l l
Chapter 49. Substance Use Disorders ..............................................................................................................190
l l l l
Chapter 50. Tuberculosis ..................................................................................................................................195
l l
Chapter 51. Upper Respiratory Tract Infection, Pharyngitis, Sinusitis, Otitis Media, and Otitis Externa ......197
l l l l l l l l l l l l
Chapter 52. Urinary Tract Infections ...............................................................................................................200
l l l l
Chapter 53. Women as Patients .......................................................................................................................203
l l l l
Chapter 54. Men as Patients ............................................................................................................................207
l l l l
Chapter 55. Pediatric Patients ...........................................................................................................................209
l l l
Chapter 57. Geriatric Patients ...........................................................................................................................213
l l l
, Woo 1
Pharmacotherapeutics for APN Prescribers, l l l Ch01
Chapter 1. The Role of the Advanced Practice Nurse as Prescriber
l l l l l l l l l l
MULTIPLE CHOICE l
1. Nurse practitioner prescriptive authority is regulated by:
l l l l l l
A. The National Council of State Boards of Nursing
l l l l l l l
B. The U.S. Drug Enforcement Administration
l l l l
C. The State Board of Nursing for each state
l l l l l l l
D. The State Board of Pharmacy
l l l l
ANS: C PTS: 1
2. The benefits to the patient of having an advanced practice registered nurse (APRN)
l l l l l l l l l l l l
prescriber include:
l l
A. Nurses know more about pharmacology than other prescribers because they take it
l l l l l l l l l l l
both in their basic nursing program and in their APRN program.
l l l l l l l l l l l
B. Nurses care for the patient from a holistic approach and include the patient in
l l l l l l l l l l l l l
decision-making regarding their care.
l l l l
C. APRNs are less likely to prescribe narcotics and other controlled substances.
l l l l l l l l l l
D. APRNs are able to prescribe independently in all states, whereas a
l l l l l l l l l l
physician’s assistant needs to have a physician supervising their practice. l l l l l l l l l
ANS: B PTS: 1
3. Clinical judgment in prescribing includes:
l l l l
A. Factoring in the cost to the patient of the medication prescribed
l l l l l l l l l l
B. Always prescribing the newest medication available for the disease process
l l l l l l l l l
C. Handing out drug samples to poor patients l l l l l l
D. Prescribing all generic medications to cut costs l l l l l l
ANS: A PTS: 1
4. The process for choosing an effective drug for a disorder includes:
l l l l l l l l l l
A. Asking the patient what drug they think would work best for them
l l l l l l l l l l l
B. Consulting nationally recognized guidelines for disease management l l l l l l
C. Prescribing medications that are available as samples before writing a prescription
l l l l l l l l l l
D. Following U.S. Drug Enforcement Administration guidelines for prescribing
l l l l l l l
ANS: B PTS: 1
5. Nonintentional nonadherence of drug therapy may occur due to: l l l l l l l l
A. Belief that medication does not work
l l l l l
B. Adverse drug reactions l l
C. Chronic conditions that require daily therapy
l l l l l
D. Forgetfulness or distraction l l
ANS: D PTS: 1
Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 6th Edition
l l l l l l l
Author: Teri Moser Woo and Wendy L. Wright
l l l l l l l
, TABLE OF CONTENT l l
Chapter l 1. l The Role of the Advanced Practice Nurse as Prescriber ................................................................4
l l l l l l l l
Chapter l 2. l Review of Basic Principles of Pharmacology ..................................................................................5
l l l l l
Chapter l 3. l Rational Drug Selection .................................................................................................................. 11
l l
Chapter l 4. l Legal and Professional Issues in Prescribing ................................................................................ 14
l l l l l
Chapter l 5. l Adverse Drug Reactions ................................................................................................................. 16
l l
Chapter l 6. l An Introduction to Pharmacogenomics .......................................................................................... 19
l l l
Chapter l 7. l Nutrition and Nutraceuticals ........................................................................................................... 22
l l
Chapter l 8. l Herbal Therapies .............................................................................................................................. 28
l
Chapter 9. Cannabis ........................................................................................................................................... 31
l l
Chapter 10. Pharmacoeconomics ....................................................................................................................... 35
l l
Chapter 11. Drugs Affecting the Autonomic Nervous System ...................................................................... 38
l l l l l l l
Chapter 12. Drugs Affecting the Central Nervous System ............................................................................. 45
l l l l l l l
Chapter 13. Drugs Affecting the Cardiovascular and Renal Systems ............................................................ 53
l l l l l l l l
Chapter 14. Drugs Affecting the Respiratory System ..................................................................................... 61
l l l l l l
Chapter 15. Drugs Affecting the Hematological System ................................................................................ 65
l l l l l l
Chapter 16. Drugs Affecting the Immune System: Vaccines and Immunoglobulins .................................... 69
l l l l l l l l l
Chapter 17. Drugs Affecting the Immune System: Immunomodulators ......................................................... 75
l l l l l l l
Chapter 18. Drugs Affecting the Gastrointestinal System ............................................................................... 77
l l l l l l
Chapter 19. Drugs Affecting the Endocrine System: Pancreatic Hormones and Antidiabetic Drugs .............. 80
l l l l l l l l l l l
Chapter 20. Drugs Affecting the Endocrine System: Pituitary, Thyroid, and Adrenal Drugs...................... 83
l l l l l l l l l l l
Chapter 21. Drugs Affecting the Reproductive System .................................................................................. 86
l l l l l l
Chapter 22. Drugs Affecting the Bones and Joints ......................................................................................... 92
l l l l l l l
Chapter 23. Drugs Affecting the Integumentary System ................................................................................. 96
l l l l l l
Chapter 24. Drugs Used to Treat Bacterial Infections ...................................................................................101
l l l l l l l
Chapter 25. Drugs Used to Treat Viral, Fungal, and Protozoal Infections ..................................................105
l l l l l l l l l l
Chapter 26. Drugs Used to Treat Inflammatory Processes ............................................................................108
l l l l l l l
Chapter 27. Drugs Used to Treat Eye and Ear Disorders .............................................................................111
l l l l l l l l l
Chapter 28. Anemia ..........................................................................................................................................113
l l
Chapter 29. Anxiety and Depression ...............................................................................................................116
l l l l
Chapter l 30. l Attention Deficit-Hyperactivity Disorder ....................................................................................120
l l
Chapter l 31. l Asthma and Allergy .....................................................................................................................122
l l
Chapter l 32. l Chronic Obstructive Pulmonary Disease .....................................................................................125
l l l
Chapter l 33. l Contraception ................................................................................................................................127
Chapter l 34. l COVID-19: Acute and Chronic ...................................................................................................130
l l l
Chapter 35. l l Dermatological Conditions ...........................................................................................................134
l
Chapter 36. l l Diabetes Management ..................................................................................................................138
l
Chapter 37.l l Gastroesophageal Reflux and Peptic Ulcer Disease...................................................................146
l l l l l
Chapter 38. l l Headaches......................................................................................................................................149
Chapter 39. Heart Failure .................................................................................................................................153
l l l
Chapter 40. HIV Disease and Acquired Immunodeficiency Syndrome .........................................................158
l l l l l l l
Chapter 41. Menopausal Hormone Therapy....................................................................................................161
l l l l
,Chapter 42. Hyperlipidemia ..............................................................................................................................164
l l
Chapter 43. Hypertension .................................................................................................................................169
l l
Chapter 44. Hyperthyroidism and Hypothyroidism ........................................................................................174
l l l l
Chapter 45. Obesity ..........................................................................................................................................177
l l
Chapter 46. Pain Management: Acute and Chronic Pain...............................................................................181
l l l l l l l
Chapter 47. Pneumonia .....................................................................................................................................185
l l
Chapter 48. Sexually Transmitted Diseases and Vaginitis .............................................................................187
l l l l l l
Chapter 49. Substance Use Disorders ..............................................................................................................190
l l l l
Chapter 50. Tuberculosis ..................................................................................................................................195
l l
Chapter 51. Upper Respiratory Tract Infection, Pharyngitis, Sinusitis, Otitis Media, and Otitis Externa ......197
l l l l l l l l l l l l
Chapter 52. Urinary Tract Infections ...............................................................................................................200
l l l l
Chapter 53. Women as Patients .......................................................................................................................203
l l l l
Chapter 54. Men as Patients ............................................................................................................................207
l l l l
Chapter 55. Pediatric Patients ...........................................................................................................................209
l l l
Chapter 57. Geriatric Patients ...........................................................................................................................213
l l l
, Woo 1
Pharmacotherapeutics for APN Prescribers, l l l Ch01
Chapter 1. The Role of the Advanced Practice Nurse as Prescriber
l l l l l l l l l l
MULTIPLE CHOICE l
1. Nurse practitioner prescriptive authority is regulated by:
l l l l l l
A. The National Council of State Boards of Nursing
l l l l l l l
B. The U.S. Drug Enforcement Administration
l l l l
C. The State Board of Nursing for each state
l l l l l l l
D. The State Board of Pharmacy
l l l l
ANS: C PTS: 1
2. The benefits to the patient of having an advanced practice registered nurse (APRN)
l l l l l l l l l l l l
prescriber include:
l l
A. Nurses know more about pharmacology than other prescribers because they take it
l l l l l l l l l l l
both in their basic nursing program and in their APRN program.
l l l l l l l l l l l
B. Nurses care for the patient from a holistic approach and include the patient in
l l l l l l l l l l l l l
decision-making regarding their care.
l l l l
C. APRNs are less likely to prescribe narcotics and other controlled substances.
l l l l l l l l l l
D. APRNs are able to prescribe independently in all states, whereas a
l l l l l l l l l l
physician’s assistant needs to have a physician supervising their practice. l l l l l l l l l
ANS: B PTS: 1
3. Clinical judgment in prescribing includes:
l l l l
A. Factoring in the cost to the patient of the medication prescribed
l l l l l l l l l l
B. Always prescribing the newest medication available for the disease process
l l l l l l l l l
C. Handing out drug samples to poor patients l l l l l l
D. Prescribing all generic medications to cut costs l l l l l l
ANS: A PTS: 1
4. The process for choosing an effective drug for a disorder includes:
l l l l l l l l l l
A. Asking the patient what drug they think would work best for them
l l l l l l l l l l l
B. Consulting nationally recognized guidelines for disease management l l l l l l
C. Prescribing medications that are available as samples before writing a prescription
l l l l l l l l l l
D. Following U.S. Drug Enforcement Administration guidelines for prescribing
l l l l l l l
ANS: B PTS: 1
5. Nonintentional nonadherence of drug therapy may occur due to: l l l l l l l l
A. Belief that medication does not work
l l l l l
B. Adverse drug reactions l l
C. Chronic conditions that require daily therapy
l l l l l
D. Forgetfulness or distraction l l
ANS: D PTS: 1
